Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Bolt Biotherapeutics, Inc. (BOLT) had Debt to Capital Ratio of 0.39 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$2.17M |
|
$-7.14M |
|
-- |
|
$2.17M |
|
$9.87M |
|
$-7.70M |
|
$0.56M |
|
$-7.14M |
|
$-7.14M |
|
$-7.14M |
|
$-7.14M |
|
$-7.14M |
|
$-7.14M |
|
$-7.70M |
|
$-7.54M |
|
1.92M |
|
1.92M |
|
$-3.72 |
|
$-3.72 |
|
| Balance Sheet Financials | |
$35.61M |
|
$1.50M |
|
$29.45M |
|
$65.05M |
|
$9.97M |
|
$20.89M |
|
$22.99M |
|
$32.95M |
|
$32.10M |
|
$32.10M |
|
$32.10M |
|
1.92M |
|
| Cash Flow Statement Financials | |
$-32.69M |
|
$43.23M |
|
$0.01M |
|
$8.97M |
|
$19.52M |
|
$10.55M |
|
$1.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.57 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.39 |
0.65 |
|
100.00% |
|
-355.14% |
|
-355.14% |
|
-- |
|
-329.37% |
|
-329.37% |
|
$-31.80M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-22.25% |
|
-22.25% |
|
-10.98% |
|
-13.48% |
|
$16.73 |
|
$-16.57 |
|
$-17.04 |
|